Impact of polypharmacy and comorbidity on survival and systemic parenteral treatment administration in a cohort of hospitalized lung-cancer patients

BACKGROUND: Although polypharmacy has been described among cancer patients, very few studies have focused on those with lung cancer. We aimed to assess whether polypharmacy and comorbidity have an impact on systemic parenteral treatment administration and survival among lung-cancer patients. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Pluchart, Hélène, Bailly, Sébastien, Chanoine, Sébastien, Moro-Sibilot, Denis, Bedouch, Pierrick, Toffart, Anne-Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290392/
https://www.ncbi.nlm.nih.gov/pubmed/37353729
http://dx.doi.org/10.1186/s12885-023-10939-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290392/
https://www.ncbi.nlm.nih.gov/pubmed/37353729
http://dx.doi.org/10.1186/s12885-023-10939-7

Ejemplares similares